Flumetasone Pivalate/Salicylic acid

特戊酸氟米松/水杨酸

Report date: 2023/04/06 20:00:19
NME

Base Information

Drug NameFlumetasone Pivalate/Salicylic acid
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionGlucocorticoid receptor agonistsCyclooxygenases inhibitors
TargetsGlucocorticoid receptorCyclooxygenases
Therapy Area/IndicationsDermatitis
Global Approved IndicationsDermatitis
Approved Indications in ChinaDermatitis
Original Approved Country/TerritoryMainland China
Original Approved DateN/A
Country/TerritoryMainland China
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsDermatitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A